Login
Israel-Hamas Conflict
Memorial Day
Motorsports
Social Media
Artificial Intelligence
Baseball
Military
Crime
Tennis
European Union
Taxes
French Open
Cannes Film Festival
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Meril Presents Successful LANDMARK RCT One-Year Results at Prestigious EuroPCR 2025

Summary by Express Healthcare
Vapi, 23rd May 2025 – Meril Life Sciences announced one-year results from its pivotal LANDMARK trial, presented during the prestigious Late-Breaking Trial session at EuroPCR 2025, one of the world’s premier cardiology conferences held annually in Paris, France. The LANDMARK trial is the first randomised non-inferiority trial comparing the balloon-expandable Myval THV series with other contemporary balloon-expandable Sapien THV series and self-ex…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All
Left
Center
Right
Express HealthcareExpress Healthcare

Meril presents successful LANDMARK RCT one-year results at prestigious EuroPCR 2025

Vapi, 23rd May 2025 – Meril Life Sciences announced one-year results from its pivotal LANDMARK trial, presented during the prestigious Late-Breaking Trial session at EuroPCR 2025, one of the world’s premier cardiology conferences held annually in Paris, France. The LANDMARK trial is the first randomised non-inferiority trial comparing the balloon-expandable Myval THV series with other contemporary balloon-expandable Sapien THV series and self-ex…

Read Full Article
presseportal.depresseportal.de

Meril Presents Successful One-Year Results of the LANDMARK-RCT Study at the Renowned EuroPCR 2025

Meril Life Sciences [Newsroom]Vapi, India (ots/PRNewswire) - First randomized head-to-head TAVI study of its kind confirms performance and safety of the Next-Gen Myval-THV series Meril Life Sciences today gave the one-year results of its pioneering LANDMARK study ... Continue reading here...Original content of: Meril Life Sciences, transmitted by news aktuell

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

presseportal.de broke the news in on Thursday, May 22, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Vapi

Vapi

Paris, France

Paris, France

News
For You
SearchBlindspotLocal